Publications

(2025). RNA Polymerase II at histone genes predicts outcome in human cancer. Science.

PDF Project DOI Preprint

(2024). Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion. Nature Communications.

Project DOI Paper

(2024). ADTnorm: Robust Integration of Single-cell Protein Measurement across CITE-seq Datasets. Under review at Nature Communications.

PDF Code Project DOI Preprint

(2024). Mitotic errors do not explain aneuploidy in cancer. Under the second round of review at Trends in Genetics.

Project

(2023). Histone Methylation Mark Analyses Distinguish Carts Manufactured from Distinct Sources and Uncover Novel Transcription Factors Associated with In Vivo Function of Carts after Infusion into DLBCL Patients That Are Not Identified By RNA-Seq. Blood.

Project DOI Paper

(2023). CUT&RUN and CUT&Tag. Choosing Genomics Tools.

Project Chapter Authors

(2022). Defining cellular population dynamics at single cell resolution during prostate cancer progression. eLife.

Project DOI Paper

(2022). Cellular profiling of leukapheresis and infusion products of patients enrolled in CD19 CAR T cell therapy identifies biomarkers associated with clinical outcomes. Cancer Research.

Project Paper

(2022). Regulatory architecture of the RCA gene cluster captures an intragenic TAD boundary and enhancer elements in B cells. Frontiers in Immunology.

Project DOI Paper

(2021). Long-Term Follow-up and Single-Cell Multiomics Characteristics of Infusion Products in Patients with Chronic Lymphocytic Leukemia Treated with CD19 CAR-T Cells. Blood.

Project DOI

(2021). Single-cell CUTTag analysis of chromatin modifications in differentiation and tumor progression. Nature Biotechnology.

Project DOI Paper

(2021). Transcriptome-wide transmission disequilibrium analysis identifies novel risk genes for autism spectrum disorder. PLOS Genetics.

PDF Project DOI

(2021). Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models. Neuro-Oncology.

Project DOI

(2020). Discovering How Heme Controls Genome Function Through Heme-omics. Cell Reports.

Project DOI Paper

(2020). Perspectives on ENCODE. Nature.

Project DOI Paper

(2019). Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer. Journal of Clinical Investigation.

Project DOI Paper

(2018). GATA/Heme Multi-omics Reveals a Trace Metal-dependent Cellular Differentiation Mechanism. Developmental Cell.

Project DOI Paper